Cannabis

Is Cannabis A Study Aid

Published

1 year ago

November 2, 2023

admin

Cannabis is the average co-ed’s drug of choice. While a lot of people encounter cannabis when they’re younger, it’s not until college the stoner persona solidifies. New college students are entering a stage where they’re able to smoke to their heart’s content without worrying about their parents or the smell of their rooms. It’s natural for them to want to smoke all the time. But is cannabis a study air, especially around finals?

Like most things marijuana, it is complicated and there isn’t a significant amount of data to support it is a big benefit. School performance while under the influence depends on a variety of factors, mainly whether or not the student actually studies while high, and the ways in which their body responds to the drug, which is affected by method, dosage and personal experience.

College Students Seek CBD For Pain And Stress Management — Photo by tortugadatacorp via Pixabay

Like enegery drinks, it is a mixed bag of results and has to do with factors like late night studying, stress, and the amount consumed. There is an assumption marijuana helps with the creativity process, which for projects could be helpful.

Depending on the dosage and strain being consumed, marijuana could help users narrow their focus of the topic they’re studying or provide new ideas students. It might make the topic at hand more engaging and entertaining, putting people in a better mood when starting to study. If the user tends to feel anxiety when studying, marijuana might help curb those impulses.

When it comes to group study sessions, marijuana might facilitate deeper conversations and more engagement from the group, it works if the user enjoys learning alongside others and talking out problems and topics.

Books About Marijuana — Photo by Caio via Pexels

The way in which cannabis is consumed plays a pivotal role as well. While edibles are discreet and powerful, they might be too strong for a relaxed study session; vaping and smoking flower might be the safest options to try out at first. Microdosing might be an option to test the waters, producing results which are not distracting and don’t derail from the user’s original purpose.

Still, since there’s not a lot of scientific data out there, it’s important to go slow. Users should monitor their dosage and pick the right occasion to consume. For instance, a school topic they enjoy will work better than one they don’t, and a low stakes situation, like a quiz or a group activity, will definitely be more manageable than a midterm.

Attending a class while super stoned doesn’t sound like the most pleasing experience, but a little toke won’t hurt anyone, especially if the class is large or if there are friends around that could provide some support and peace of mind.

As always, for better recommendations, it helps to visit a dispensary and to talk with an expert, who might recommend a product that’s manageable and suitable for creating a focused mentality. Most importantly, the biggest piece of advice would be to be careful. While marijuana can be creatively stimulating, it can also make people’s brain feel hazy and paranoid. Studying with weed might not be for everyone, and it’s up to the user to figure out if they can manage the side effects.

Limited research has shown that marijuana’s negative effects on attention, memory, and learning can last for days or weeks which could have a rough impact on test results.

Source link

Cannabis

White House Finally Comments On Marijuana Industry

Published

12 hours ago

April 1, 2025

admin

Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.

The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.

The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.

During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.

The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.

The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.

While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.

Source link

Cannabis

This State’s Cannabis Revenue Keeps Pouring In

Published

1 day ago

March 31, 2025

admin

States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.

The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.

RELATED: Mike Johnson And Marijuana

“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”

Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.

States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.

In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.

Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.

The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.

This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.

Source link

Cannabis

Mixed Messages From The Feds About Cannabis

Published

4 days ago

March 28, 2025

admin

The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.

The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.

The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.

The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.

Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.

In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.

This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.

Source link